Vivian Zhang

Vivian Zhang is a seasoned professional in the biotech and healthcare sectors, currently serving as a Bio-Industry Committee Member for the American Society of Gene & Cell Therapy and an investor focused on companies at the intersection of biotech, health tech, and AI. With experience as the Group Director of Corporate Development at GenScript from 2023 to 2025, prior roles include strategic consulting at IQVIA and management consulting in life sciences at L.E.K. Consulting. Vivian has a background in business development at Philips and has contributed to research at Duke University, where work supported the Precision Medicine Initiative. Educational qualifications include a PhD candidate and MS in Management from Duke, an MBA from INSEAD, and a foundational education at Sun Yat-sen University.